Publication Name	World Journal of Gastroenterology
Manuscript ID	82919
Country	United States

Received	2022-12-29 22:17
Peer-Review Started	2022-12-29 22:19
To Make the First Decision
Return for Revision	2023-02-15 06:51
Revised	2023-02-25 17:20
Second Decision	2023-04-28 03:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-04-28 17:43
Articles in Press	2023-04-28 17:43
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-05-03 21:41
Typeset the Manuscript	2023-05-24 10:09
Publish the Manuscript Online	2023-06-01 13:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Gowthami Sai Kogilathota Jagirdhar, Rakhtan K Qasba, Harsha Pattnaik, Kaanthi Rama, Akshat Banga, Shiva Teja Reddy, Anna Carolina Flumignan Bucharles, Rahul Kashyap, Praveen Reddy Elmati, Vikas Bansal, Yatinder Bains, Theodore DaCosta and Salim Surani
ORCID	Author(s) ORCID Number Gowthami Sai Kogilathota Jagirdhar http://orcid.org/0000-0003-1855-0863 Rakhtan K Qasba http://orcid.org/0000-0001-5051-9319 Harsha Pattnaik http://orcid.org/0000-0002-6316-7006 Kaanthi Rama http://orcid.org/0000-0002-1691-7812 Akshat Banga http://orcid.org/0000-0003-2626-8219 Anna Carolina Flumignan Bucharles http://orcid.org/0000-0002-8431-2495 Rahul Kashyap http://orcid.org/0000-0002-4383-3411 Praveen Reddy Elmati http://orcid.org/0000-0003-1283-2368 Vikas Bansal http://orcid.org/0000-0001-6047-5559 Yatinder Bains http://orcid.org/0000-0002-6331-1194 Theodore DaCosta http://orcid.org/0000-0002-1805-6323 Salim Surani http://orcid.org/0000-0001-7105-4266
Funding Agency and Grant Number
Corresponding Author	Salim Surani, FCCP, MD, MHSc, Professor, Department of Medicine, Texas A&M University, Administration Building, 400 Bizzell St, College Station, TX 77843, United States. srsurani@hotmail.com
Key Words	Non-alcoholic fatty liver; Fatty liver; Coronavirus; COVID-19; Metabolic associated fatty liver
Core Tip	Metabolic-associated fatty liver disease (MAFLD) is like non-alcoholic fatty liver disease (NAFLD) and is a hepatic presentation of metabolic syndrome. NAFLD and MAFLD and widely prevalent. It is estimated that 25% of the United States population have this condition. The association and effect size between fatty liver disease and coronavirus disease 2019 (COVID-19) infection is still unconfirmed. The discrepancies in the available literature may be due to study design, confounding, small study population, and heterogeneity. We performed a systematic review and meta-analysis to study the impact of NAFLD/MAFLD on mortality, hospitalization, hospital length of stay, and supplemental oxygen utilization in COVID-19 patients.
Publish Date	2023-06-01 13:04
Citation	Jagirdhar GSK, Qasba RK, Pattnaik H, Rama K, Banga A, Reddy ST, Flumignan Bucharles AC, Kashyap R, Elmati PR, Bansal V, Bains Y, DaCosta T, Surani S. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(21): 3362-3378
URL	https://www.wjgnet.com/1007-9327/full/v29/i21/3362.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i21.3362

Full Article (PDF)	WJG-29-3362.pdf
Full Article (Word)	WJG-29-3362.docx
Manuscript File	82919-Review-FilipodiaCL.docx
Answering Reviewers	82919-Answering reviewers.pdf
Audio Core Tip	82919-Audio core tip.mp3
Biostatistics Review Certificate	82919-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	82919-Conflict-of-interest statement.pdf
Copyright License Agreement	82919-Copyright license agreement.pdf
Supplementary Material	82919-Supplementary material.pdf
Peer-review Report	82919-Peer-review(s).pdf
Scientific Misconduct Check	82919-Bing-Wang JJ-2.png
Scientific Editor Work List	82919-Scientific editor work list.pdf
CrossCheck Report	82919-CrossCheck report.pdf